Who owns Vascular Biogenics?
- CUSIP Number: m96883109
Tip: Access positions for across all investors
Analyze quarterly positions in Vascular Biogenics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vascular Biogenics stock
Who bought or sold Vascular Biogenics this quarter?
There are no current stakeholders of Vascular Biogenics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Vascular Biogenics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squarepoint Ops | Sep 2023 | 227k | $55k |
| Two Sigma Securities | Sep 2023 | 53k | $13k |
| Catalyst Financial Partners | Sep 2023 | 39k | $9.5k |
| Two Sigma Investments | Sep 2023 | 33k | $8.0k |
| Advisor Group Holdings | Sep 2023 | 22k | $5.4k |
| HBK Sorce Advisory | Sep 2023 | 21k | $5.0k |
| Spectrum Planning & Advisory Services | Sep 2023 | 16k | $3.9k |
| Two Sigma Advisers | Sep 2023 | 15k | $3.7k |
| Harel Insurance Investments & Financial Services | Sep 2023 | 11k | $3.0k |
| Bank of America Corporation | Sep 2023 | 8.2k | $2.0k |
| Baystate Wealth Management | Sep 2023 | 1.5k | $367.050000 |
| Jpmorgan Chase & Co | Sep 2023 | 1.5k | $366.000000 |